ID

28997

Descripción

A phase IV, open, multicentre study to assess the immunogenicity and reactogenicity of GlaxoSmithKline Biologicals’ DTPa-HBV-IPV/Hib vaccine (Infanrix hexa) given as a booster at 18-24 months of age to pre-term children who have received a three-dose primary immunization course with the same vaccine in study 217744/090.

Palabras clave

Versiones (1)
  1. 20/2/18 20/2/18 -
Titular de derechos de autor

GlaxoSmithKline (GSK)

Subido en

20 de febrero de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

DTPa-HBV-IPV/Hib vaccine (Infanrix-hexa) Study ID: 101518

Inglés

Informed consent

2 formularios  
Informed consent
Descripción

Informed consent

Alias
UMLS CUI-1
C0021430
Subject No.
Descripción

Subject No.

Tipo de datos

integer

Alias
UMLS CUI [1]
C2348585
Date
Descripción

Date

Tipo de datos

date

Alias
UMLS CUI [1]
C0011008
Participant’s parent or legal guardian’s first name and family name
Descripción

The DTPa-HBV-IPV/Hib vaccine study has been clearly explained to me and I have read and understood the information provided. I agree that my [son/daughter/ward] be enrolled in the study. I understand that I have the right to decline to enter my [son/daughter/ward] into the study and to withdraw from it at any time for any reasons, without consequence to his/her present or future health care and attention which my child/ward receives from his/her healthcare provider. I have been made aware of my right to access and request correction of my child’s/ward’s personal data. I acknowledge that I have received a copy of this form for future reference.

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0027365
UMLS CUI [1,2]
C0030551
UMLS CUI [1,3]
C0085537
Participant’s Name, (First Name, Family Name)
Descripción

Patient's name

Tipo de datos

text

Alias
UMLS CUI [1]
C1299487
Parent/Guardian’s name, (First Name, Family Name)
Descripción

Parent/Guardian’s name

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0023226
UMLS CUI [1,2]
C0027365
Parent/Guardian’s signature
Descripción

Parent/Guardian’s signature

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1519316
UMLS CUI [1,2]
C0030551
UMLS CUI [1,3]
C1274041
Relationship to participant
Descripción

Relationship to participant

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0439849
UMLS CUI [1,2]
C0679646
Participant’s main address
Descripción

Participant’s main address

Tipo de datos

text

Alias
UMLS CUI [1]
C0421449
Participant’s phone number
Descripción

Participant’s phone number

Tipo de datos

integer

Alias
UMLS CUI [1]
C1515258
Date
Descripción

Date

Tipo de datos

date

Alias
UMLS CUI [1]
C0011008
Time
Descripción

Time

Tipo de datos

time

Alias
UMLS CUI [1]
C0040223
Witness
Descripción

Witness

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0682356
UMLS CUI [1,2]
C0021430
Name
Descripción

Statement by Doctor, Nurse or Project Assistant who conducted the informed consent discussion: I have carefully explained the nature, demands and foreseeable risks and benefits of the vaccination study to the person named above and witnessed the completion of the written consent form.

Tipo de datos

text

Alias
UMLS CUI [1]
C2826892
Signature
Descripción

Signature

Tipo de datos

text

Alias
UMLS CUI [1]
C2346576
Designation
Descripción

Designation

Tipo de datos

text

Alias
UMLS CUI [1]
C0442504
Date
Descripción

Date

Tipo de datos

date

Alias
UMLS CUI [1]
C0011008
Time
Descripción

Time

Tipo de datos

time

Alias
UMLS CUI [1]
C0040223
Volver a la parte superior de la página

Similar models

Informed consent

2 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C0021430 (UMLS CUI-1)
Subject No.
Item
Subject No.
integer
C2348585 (UMLS CUI [1])
Date
Item
Date
date
C0011008 (UMLS CUI [1])
Name
Item
Participant’s parent or legal guardian’s first name and family name
text
C0027365 (UMLS CUI [1,1])
C0030551 (UMLS CUI [1,2])
C0085537 (UMLS CUI [1,3])
Patient's name
Item
Participant’s Name, (First Name, Family Name)
text
C1299487 (UMLS CUI [1])
Parent/Guardian’s name
Item
Parent/Guardian’s name, (First Name, Family Name)
text
C0023226 (UMLS CUI [1,1])
C0027365 (UMLS CUI [1,2])
Parent/Guardian’s signature
Item
Parent/Guardian’s signature
text
C1519316 (UMLS CUI [1,1])
C0030551 (UMLS CUI [1,2])
C1274041 (UMLS CUI [1,3])
Relationship to participant
Item
Relationship to participant
text
C0439849 (UMLS CUI [1,1])
C0679646 (UMLS CUI [1,2])
Participant’s main address
Item
Participant’s main address
text
C0421449 (UMLS CUI [1])
Participant’s phone number
Item
Participant’s phone number
integer
C1515258 (UMLS CUI [1])
Date
Item
Date
date
C0011008 (UMLS CUI [1])
Time
Item
Time
time
C0040223 (UMLS CUI [1])
Witness
Item
Witness
text
C0682356 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
Name
Item
Name
text
C2826892 (UMLS CUI [1])
Signature
Item
Signature
text
C2346576 (UMLS CUI [1])
Designation
Item
Designation
text
C0442504 (UMLS CUI [1])
Date
Item
Date
date
C0011008 (UMLS CUI [1])
Time
Item
Time
time
C0040223 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial